simendan has been researched along with Blood Pressure, High in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydede, H; Erbüyün, K; Erhan, Y; Ok, G; Tekin, I; Tok, D; Türköz, E; Vatansever, S | 1 |
| Biala, A; Finckenberg, P; Kaheinen, P; Levijoki, J; Louhelainen, M; Luft, FC; Martonen, E; Merasto, S; Mervaala, E; Muller, DN | 1 |
| Gautreux Minaya, S; Lobo Martínez, P; Oulego Erroz, I; Rodríguez Fernández, LM | 1 |
| Biala, A; Finckenberg, P; Korpi, A; Levijoki, J; Loytainen, M; Martonen, E; Mervaala, E | 1 |
| Colucci, WS; Finckenberg, P; Haikala, H; Kaheinen, P; Kytö, V; Leskinen, H; Levijoki, J; Louhelainen, M; Merasto, S; Mervaala, EM; Pollesello, P; Vahtola, E | 1 |
5 other study(ies) available for simendan and Blood Pressure, High
| Article | Year |
|---|---|
Effects of levosimendan and dobutamine on experimental acute lung injury in rats.
Topics: Acute Lung Injury; Animals; Cardiotonic Agents; Dobutamine; Hydrazones; Hypertension; Immunohistochemistry; In Situ Nick-End Labeling; Interleukin-1beta; Lung; Male; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pyridazines; Rats; Rats, Wistar; Simendan; Tumor Necrosis Factor-alpha | 2009 |
Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure.
Topics: Angiotensin II; Angiotensinogen; Animals; bcl-2-Associated X Protein; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Heart; Heart Failure; Heart Rate; Humans; Hydrazones; Hypertension; Major Histocompatibility Complex; Male; Pyridazines; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan | 2010 |
Treatment of acute heart failure using levosimendan for a patient with dilated cardiomyopathy, chronic renal failure, and hypertension.
Topics: Acute Disease; Adolescent; Cardiomyopathy, Dilated; Cardiotonic Agents; Diuresis; Dose-Response Relationship, Drug; Echocardiography, Doppler, Pulsed; Follow-Up Studies; Glycogen Storage Disease Type I; Heart Failure; Humans; Hydrazones; Hypertension; Infusions, Intravenous; Kidney Failure, Chronic; Male; Myocardial Contraction; Pyridazines; Simendan; Stroke Volume | 2011 |
Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Diet, Sodium-Restricted; Echocardiography; Heart; Heart Failure; Heart Rate; Hydrazones; Hypertension; Kidney; Male; Myocytes, Cardiac; Pyridazines; Rats; Rats, Inbred Dahl; RNA, Messenger; Simendan; Sodium Chloride, Dietary; Sodium, Dietary; Tetrazoles; Valine; Valsartan; Vasodilator Agents; Ventricular Remodeling | 2011 |
Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats.
Topics: Animals; Apoptosis; Atrial Natriuretic Factor; Hydrazones; Hypertension; Male; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Norepinephrine; Osteopontin; Pyridazines; Rats; Rats, Inbred Dahl; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Sodium-Calcium Exchanger; Vasodilator Agents; Ventricular Remodeling | 2007 |